| Code | Description | Claims | Beneficiaries | Total Paid |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
160,054 |
45,160 |
$5.64M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
60,457 |
15,751 |
$703K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,247 |
6,164 |
$158K |
| 99451 |
|
1,886 |
1,157 |
$29K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,359 |
594 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,115 |
472 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
329 |
280 |
$3K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
835 |
389 |
$2K |
| 99001 |
|
50 |
38 |
$81.00 |
| 87070 |
|
22 |
15 |
$36.31 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
337 |
100 |
$0.00 |